Search Results

Track the progress and impact of key T2D Network initiatives. Explore ongoing projects, engagement metrics, and collaboration efforts aimed at improving Type 2 Diabetes care and awareness. T2D Network Project Dashboard The Dashboard provides a real-time view of key initiatives aimed at improving T2D support and awareness. Projects Overview Established Resources Collaboration IPTN Remission Activities Mental Health T2D Prevention Demonstration Project Metis Education Strategy NHS Diabetes Prevention Program Review Research Partnerships South Asian Health Strategy T2D Data Set Development T2D Network Redevelopment T2D Network Website Refresh Last updated February 2026 Explore Our Comprehensive Medical Treatments Key Activities ✅Develop relationship and share ✅ Identify gaps in information ✅ Link systems together - go live Completion Date 👉March 2025 - March 2026 Established Resources and T2D Network Connections Brief Project Objective Establish relationship with existing resources (BC Community Health Centres) to enable collaboration on T2D education resources. Identify gaps in existing T2D education resources provided by BC CHC that can be filled by T2DN resources. Progress towards a centralized hub of education resources with the BC Diabetes Collaborative (a group of ~50 diabetes nurse educators across all the BC health authorities). Expected Results/Impacted Population Create an organizational partnership with BC CHC. Create a “package” of resources that can be integrated into their existing resources. Ensure the BC population using the BC CHC service have access to the information they need to maximize the educational benefit for patients. Key Activities ✅Rural remission toolkit ✅Culturally specific approaches ✅Support community engagement Completion Date 👉March - August 2025 IPTN Remission Activities Brief Project Objective Create an instructional/educational “Tool Kit” for communities to engage in T2D Remission care. Create culturally tailored T2D remission resources for South Asian community members, based on the previously developed “Tool Kit”. Expected Results/Impacted Population Rural communities across BC will have greater access to IPTN T2D remission resources. Remission “Tool Kit” implemented into South Asian project as one of many tools to aid the South Asian community in T2D self-care. Key Activities ✅ Phase 1 - Information sharing ✅ Phase 2 - Sequenced ✅ Evaluation Completion Date 👉June 2025 Mental Health / T2D Prevention Demonstration Project Brief Project Objective Strengthen information sharing between BounceBack (BB) and Small Steps for Big Changes (SSBC) , to address T2D prevention and mental health. Align intake, referrals, data sharing, and evaluation processes for deeper program integration. Develop a shared evaluation framework with key performance indicators (KPIs) and qualitative insights from staff and leadership. Expected Results/Impacted Population Increase awareness of both programs through cross-promotion. Support individuals in Prince George, Summerland, Oliver, and Grand Forks with mental health and T2D prevention. Virtual option to participate rolled out for SSBC across interior and northern BC. Establish shared KPIs, data-sharing agreements, and cross-promotional marketing. Develop an evaluation framework, focus groups with participants and coaches, and a demonstration project report. Key Activities ✅ Consult with Metis community ✅ Develop appropriate materials ✅ Education support Completion Date 👉TBD Metis Education Strategy Brief Project Objective Assess and understand the needs of the Métis community regarding T2D awareness, education, and self-care - using a survey tool. Develop culturally tailored resources to empower Métis individuals in managing their health, inspired by the T2DN South Asian project. Implement a distribution strategy to reach those most in need and evaluate the project's impact. Expected Results/Impacted Population First round of in-person surveys completed (~100) November 2025. Digital survey's prepared for community distribution December 2025. Links made between partner organizations – Metis Federation and IPTN for T2D focused remission opportunities. Collaborate with Metis Federation to develop appropriate T2D support plan. There are just under 100,000 self-identified Metis in BC. Metis Nation BC has ~25,000 members. We do not know how many members Metis Federation BC currently has. Key Activities ✅ Review & Data Collection ✅ Stakeholder Engagement ✅ Analysis & Recommendations Completion Date 👉December 2023 Journal Publication 👉 Journal of Diabetology December 2023 National Health Service Diabetes Prevention Program Review Brief Project Objective Review diabetes prevention programs within the NHS, focusing on Type 2 diabetes (T2D) prevention. Evaluate the effectiveness of the Diabetes Prevention Program (DPP) in reducing T2D incidence. Assess the structure, reach, and outcomes of lifestyle interventions, community outreach, and healthcare system support. Analyze evidence-based strategies for T2D prevention and address diverse population needs. Expected Results/Impacted Population Evaluate program effectiveness in preventing T2D and improving patient outcomes. Assess impact on high-risk groups (e.g., prediabetes, ethnic minorities, socioeconomically deprived). Identify success factors like personalized care, patient engagement, and digital tools. Provide recommendations to improve program accessibility, equity, and sustainability. Understand financial implications and cost-effectiveness of prevention programs. Key Activities ✅Seed funding grant ✅Research partnership ✅Knowledge translation Completion Date 👉TBD Research Partnerships Brief Project Objective To seek and support projects that address specific research questions related to T2D prevention, self-management, and care through seed funding grants and partnership with research groups. Establish and strengthen research partnerships with academic and research institutions, healthcare organizations, and community partners to advance collaborative research on T2D prevention and support in the community. Expected Results/Impacted Population Facilitation of research that directly addresses key knowledge gaps in T2D, fostering innovation and collaboration through funded projects that generate actionable insights and contribute to future initiatives. Expanded research collaborations leading to more educational opportunities, joint grant applications, and knowledge translation initiatives. Key Activities ✅ Screening clinic prototype ✅ Develop appropriate materials ✅ Integrate SA perspectives Completion Date 👉Ongoing expansion Journal Publication 👉 Clinical Journal of Diabetes Care and Control Sept 2024 South Asian Health Strategy Brief Project Objective Support a community T2D screening initiative run by a partner pharmacy to increase screening availability in the South Asian Surrey community, and develop South Asian T2D care knowledge within the T2DN. Culturally tailored materials developed to increase the agency of South Asian people to self-care. Completed in conjunction with IPTN. Ensure South Asian patient partner engagement in Stigma project. Expected Results/Impacted Population Community screening session successfully conducted at Guru Nanak Gurdwara in conjunction with CINS, Naz’s Pharmacy, UBC Newcomer Health Hub volunteers, UBC South Asian Health Club medical student volunteers, and a Surrey North Delta Division of Family Practice patient attachment specialist. T2D Network staff attended the session and are formalizing learnings for future sessions. Expansion of Peace Arch Hospital Foundation funded T2D screening model into the South Surrey / White Rock area. Almost 474,000 individuals of South Asian descent in BC. T2D culturally tailored resources fill an identified gap in the self-care resources available for South Asians. Key Activities ✅Secure partnerships ✅ Establish relevant T2D data set ✅ Assess impact and monitor Completion Date 👉April - May 2025 T2D Data Set Development Brief Project Objective Increase access, quantity, and accuracy of T2D focused data within BC. Incorporate data into T2DN initiative evaluations to more accurately establish performance. Expected Results/Impacted Population Indirectly supports all projects the T2DN engages in. Creates a direct performance measure for T2DN projects. Key Activities ✅T2D Network education ✅ Increase awareness ✅ Membership drive Completion Date 👉Ongoing T2D Network Development Brief Project Objective Patient orientated newsletter completed and November dispersal scheduled. Vodcast recorded and promoted with Dr. Shazhan Amed covering innovations in diabetes care including the integration of health information to improve patient outcomes. Developing marketing plan in conjunction with sponsored NGO ad services to increase material distribution. T2D focused social media plan being executed in November (Diabetes Awareness Month) with multiple collaborations incorporated. Expected Results/Impacted Population Improve T2D prevention and support knowledge for individuals and caregivers in BC. Strengthen knowledge-sharing among healthcare providers, researchers, and experts through accessible educational content. Conduct patient engagement meeting to understand what gaps may be present. Investigate grant opportunities to advance T2D specific initiatives. Key Activities ✅Patient/provider engagement ✅Website redesign ✅ Comms and marketing Completion Date 👉Feb/March 2025 Journal Publication 👉 Publication in the Journal of Medical Research and Innovation T2D Network Website Refresh Brief Project Objective Establish patient and provider advisory groups to guide website design, resource needs, and cultural relevance. Redesign a user-centered, culturally inclusive website to improve access to credible resources, coordination, and self-management support for individuals at risk of or living with T2D in BC. Increase awareness of the T2D Network as a resource hub through targeted email and social media campaigns. Expected Results/Impacted Population Integrate patient and provider feedback into website design and resources. Develop a report on engagement insights for future projects. Enhance user engagement through increased website traffic, positive feedback, and improved resource access for T2D prevention and management. Boost utilization of T2D Network resources through higher website visits, social media interactions, and feedback from healthcare professionals and individuals with T2D. Persona's website page launched for personalized patient navigation. Stigma against diabetes resources incorporated into new webpage.

Review the guidelines and terms of use for participating in the diabetes care forum. Support Forum Terms of Use, Privacy, & Code of Conduct Welcome to the Type 2 Diabetes Support Forum Thank you for visiting the Type 2 Diabetes Support Forum, a part of the T2D Network, an initiative of the Institute of Health Systems Transformation and Sustainability (IHSTS). This forum is designed to create an online space for people living in British Columbia who have an interest in pre-diabetes or diabetes and are looking for peer support. By accessing or using this forum, you agree to comply with and be bound by the following Terms of Use. If you do not agree with these terms, please do not use the forum. Terms of Use 1. Eligibility You must be at least 18 years old to use this forum. By using the forum, you represent and warrant that you meet this age requirement. 2. User Content You are solely responsible for any content you post or share on the forum, including but not limited to text, images, and links. You agree not to post any content that is unlawful, defamatory, abusive, or otherwise objectionable. IHSTS reserves the right to remove any content that violates these Terms of Use or is otherwise deemed inappropriate. 3. Moderation The forum may be moderated to ensure compliance with these Terms of Use. IHSTS reserves the right to remove or edit content, suspend or terminate user accounts, and take other actions as necessary to maintain the integrity of the forum. 4. Disclaimers The forum is provided on an "as is" basis. IHSTS and the T2D Network make no warranties or representations regarding the accuracy, reliability, or completeness of any content on the forum. Your use of the forum is at your own risk. 5. Limitation of Liability IHSTS shall not be liable for any direct, indirect, incidental, or consequential damages arising from your use of the forum. This includes, but is not limited to, damages related to loss of data, interruption of service, or any other damages arising from the use or inability to use the forum. 6. Changes to Terms IHSTS reserves the right to modify these Terms of Use at any time. Any changes will be posted on this page, and your continued use of the forum constitutes your acceptance of the revised terms. 7. Governing Law These Terms of Use are governed by and construed in accordance with the laws of British Columbia, Canada, without regard to its conflict of law principles. Contact Us If you have any questions about these Terms of Use, please contact us at T2DNetwork@IHSTS.ca Privacy Policy Your privacy is important to us. This Privacy Policy outlines how the T2D Network, a project of IHSTS, collects, uses, and protects your personal information when you use the Type 2 Diabetes Support Forum. 1. Information Collection We collect the following types of information: - Personal Information: When you register for an account, you may provide personal information such as your name, email address, and any other information you choose to share. - Usage Data: We collect data about your interactions with the forum, including your IP address, browser type, and the pages you visit. 2. Use of Information We use your information for the following purposes: - To provide and maintain the forum. - To improve the forum’s functionality and user experience. - To communicate with you regarding your account and any changes to the forum. - To analyze usage patterns and enhance the overall quality of the forum. 3. Data Sharing We do not sell or rent your personal information to third parties. We may share your information if required by law or to protect the rights and safety of IHSTS and others. 4. Security We implement reasonable measures to protect your information from unauthorized access, disclosure, or destruction. However, no security system is impenetrable, and we cannot guarantee absolute security. 5. Your Rights You have the right to access, correct, or delete your personal information. To exercise these rights, please contact us at T2DNetwork@IHSTS.ca 6. Changes to Privacy Policy We may update this Privacy Policy from time to time. Any changes will be posted on this page, and your continued use of the forum constitutes your acceptance of the revised policy. Contact Us For any questions regarding this Privacy Policy, please contact us at T2DNetwork@IHSTS.ca Code of Conduct To ensure a positive and supportive environment, we ask all members of the Type 2 Diabetes Support Forum to adhere to the following Code of Conduct. This forum is a place for individuals in British Columbia who are living with or interested in pre-diabetes or diabetes to connect and offer peer support. By participating in the forum, you agree to follow these guidelines. 1. Respect and Courtesy Treat all forum members with respect and courtesy. Personal attacks, harassment, and discriminatory remarks will not be tolerated. Engage in discussions with kindness and empathy, recognizing that everyone’s experience with diabetes is unique. 2. Relevant and Constructive Content Keep discussions relevant to Type 2 diabetes and related topics. Provide constructive feedback and avoid spreading misinformation. Your contributions should aim to support and inform fellow members in a positive manner. 3. Privacy and Confidentiality Respect the privacy of other members. Do not share personal information about other members without their consent. Avoid posting or requesting sensitive personal health information that could compromise privacy. 4. No Spamming or Self-Promotion Avoid posting unsolicited advertisements, promotional content, or spam. Any self-promotion must be directly relevant to the forum’s purpose and pre-approved by the moderators. 5. Compliance with Laws Ensure that your posts and interactions comply with all applicable laws and regulations. 6. Reporting Issues If you encounter any issues or observe behavior that violates this Code of Conduct, please report it to the forum moderators using the provided reporting tools. 7. Consequences of Violations Violations of this Code of Conduct may result in actions such as content removal, suspension, or termination of your forum account. The severity of the action will depend on the nature of the violation. 8. Updates to Code of Conduct We may update this Code of Conduct as needed. Any changes will be communicated through the forum, and continued participation signifies your acceptance of the revised code. Contact Us For any questions or concerns regarding the Code of Conduct, please contact us at T2DNetwork@IHSTS.ca

A dedicated hub for healthcare providers to access diabetes care tools, guidelines, and referral resources. Healthcare Providers & Researchers Resources Empowering You with the Essential Information to Manage and Prevent Type 2 Diabetes Clinical Guidelines and Best Practice Access the latest guidelines on T2D prevention and management to ensure evidence-based care. Patient Education Resources Access our comprehensive patient education resources designed specifically for clinicians managing Type 2 Diabetes. Interactive Tools and Resources Utilize powerful tools like risk calculators and decision aids to optimize patient outcomes. Professional Education Materials Explore comprehensive certification programs and resources to enhance your professional practice. Referral and Support Services Connect with a broad network of local and national referral services to support patient care. Read the Latest Diabetes News Stay up-to-date with the latest advancements in diabetes research and treatment through our curated diabetes news updates. Indigenous Tailored Resources Tailored resources for Indigenous communities focus on culturally relevant diabetes prevention and management strategies that integrate traditional practices. South Asian Tailored Resources Resources for South Asian communities emphasize culturally appropriate dietary advice and lifestyle strategies, aiming to prevent and manage Type 2 diabetes. East Asian Tailored Resources Resources for Asian communities emphasize culturally appropriate dietary advice and lifestyle strategies, aiming to prevent and manage Type 2 diabetes. Explore the T2D Resources Archive/Library Dive into our comprehensive archive, where you’ll find past webinars, vodcasts, podcasts, publications, reports, and more. Diabetes Stigma Diabetes stigma unfairly blames and isolates people, making management harder and mental health worse. It affects people with diabetes everyday. Seek support here. Join the Network Connect with us and share your expertise by joining our supportive and informative healthcare provider & researcher network. Help us Spread the Word Print & Share Are you looking for T2D Network materials to share with healthcare professionals and patients? Print and share flyers and brochures here.

Key Insights into Blood Sugar Management ✅ Blood sugar responses differ greatly between individuals. ✅ “Carb-response types” reflect metabolism, not just food. ✅ Insulin-resistant people may not benefit from fiber/protein preloads. ✅ Molecular and gut microbiome profiles influence glucose spikes. ✅ Precision nutrition using CGM and metabolic data is the future. An interesting study published in Nature Medicine on June 4, 2025, is changing how we think about blood sugar after meals. Traditionally, foods have been labeled by their glycemic index, suggesting a “one-size-fits-all” approach. However, this research shows that your body’s response to food, particularly your post-meal blood sugar spike, is shaped more by your metabolism than by the food itself. This insight could transform how we prevent and manage type 2 diabetes (T2D) and cardiovascular disease. How the Study Was Conducted Fifty-five adults without diabetes participated in a carefully designed study. Researchers used Continuous Glucose Monitors (CGMs) to track real-time blood sugar changes as participants ate seven carbohydrate-rich meals. These meals included rice, bread, potatoes, pasta, grapes, beans, and mixed berries. Each meal contained 50 grams of carbohydrate, and participants repeated meals to ensure consistent results. Beyond monitoring blood sugar, the team measured metabolic health using gold-standard tests for insulin resistance and beta cell function. They also collected detailed molecular data from blood and stool samples to uncover links between glucose responses, metabolites, fats, proteins, and even gut microbes. Individual Variability in Blood Sugar Responses One of the most striking findings was the variability in responses. Some people had high spikes after rice, while others spiked after potatoes or bread. Researchers categorized participants into different “carb-response types” based on which foods triggered the largest glucose increase: Rice-spikers Potato-spikers Grape-spikers Bread-spikers Interestingly, these patterns reflected each person’s underlying metabolism. Potato-spikers tended to have higher insulin resistance, while grape-spikers were more insulin sensitive. Bread-spikers had higher blood pressure. Rice-spikers, the largest group, included many individuals of Asian descent. This clearly shows that blood sugar responses are a personal signature of your physiology, not a fixed property of the food. The Impact of Metabolic Health on Meal Responses The study also explored whether adding fiber, protein, or fat before a high-glycemic meal could blunt the sugar spike. The results were fascinating. People who were insulin sensitive saw real benefits; fiber and protein reduced their glucose peaks. However, for those who were insulin resistant, these strategies had little effect. In other words, the very people most at risk for high blood sugar may not respond to generic dietary tricks. To give some numbers, potato spikes were 179% higher in insulin-resistant individuals than in insulin-sensitive ones, and pasta spikes were 152% higher. The research also highlighted a simple clinical metric, the Potato vs. Grape ratio , that may help identify insulin resistance in a non-invasive way, potentially serving as a game-changing tool for clinicians. Molecular Insights and Future Directions This study didn’t stop at blood sugar. Molecular profiling revealed distinct metabolic signatures. Potato-spikers had higher triglycerides and fatty acids, while bread-spikers showed elevated N1-Methyladenosine, which is linked to high blood pressure. Certain gut microbes also correlated with individual glucose responses, emphasizing the role of the microbiome in metabolism. A particularly cutting-edge aspect is the idea that combining CGM data with multi-omics profiling could allow for truly precision nutrition plans. Imagine a future where your meals are optimized not just by calorie or carbohydrate content, but by your unique metabolic and molecular profile—a personalized diet for preventing diabetes before it starts. More Evidence on Blood Sugar Responses An earlier study in 2019 showed the same key principle: post-meal glucose responses vary widely between people, and generic dietary advice may miss the mark. In this study of adults without diabetes, researchers found that men and women responded differently to the same meal. Their postprandial glycemic responses (PPGRs), as measured with CGMs , diverged substantially depending on nutrients and sex, not just the carbohydrate content. Another strong body of evidence comes from a landmark “real-world meals” study 01481-6?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0092867415014816%3Fshowall%3Dtrue) from 2015. In this study, a large cohort of ~800 people logged almost 47,000 meals while wearing CGMs. The authors demonstrated very high inter-individual variability in PPGRs to identical meals. They built a machine-learning model that integrated personal blood parameters, dietary habits, anthropometrics, physical activity, and gut microbiome data. This model achieved much better prediction of PPGRs than traditional carbohydrate-counting or calorie-based approaches. The success of this study in predicting individual glycemic responses and improving them through personalized diet interventions strongly supports the concept advanced by the 2025 paper: PPGRs are not simply about the food, but about “who’s eating it.” Together, these findings build a strong case for a shift toward precision nutrition. This involves using CGM, phenotyping %20and%20environmental%20factors.) and possibly microbiome data .) to tailor dietary advice individually, rather than relying on generic glycemic index tables or broad dietary recommendations. The Importance of Personalized Nutrition For individuals managing their blood sugar, the key takeaway is that your response is unique. What works for someone else might not work for you. Monitoring your own glucose can guide smarter food choices. Simple strategies like adding fiber or protein can help, but only if your body is responsive. For healthcare providers, this research highlights the limitations of generalized dietary advice. Understanding each patient’s metabolic phenotype can help design personalized nutrition interventions that may be far more effective for preventing or managing T2D and related conditions. These studies provide strong evidence that post-meal glucose spikes are deeply individual and rooted in measurable metabolic and molecular traits. This opens the door to truly personalized nutrition strategies . Blog topic suggested by Sean McKelvey from the Institute for Personalized Therapeutic Nutrition .

February is Heart Month in Canada. This is a time to raise awareness about cardiovascular health. For those living with diabetes, heart disease is the leading cause of death . Adults with diabetes are more than 3 times more likely to die from heart disease than those without diabetes ( 65-80% ). These statistics are alarming, but the situation is even more concerning. A nationwide Danish study published (2025) in the European Heart Journal found that people with T2D were 6.5 times more likely to experience sudden cardiac death (SCD) than those without diabetes. Individuals with type 1 diabetes faced a 3.7-fold increased risk. Among adults under 50, the relative risk was even higher. Younger patients living with diabetes experienced a sevenfold increase in SCD compared to their peers. Several mechanisms contribute to this heightened risk. Diabetes accelerates the development of ischaemic heart disease, which can lead to fatal arrhythmias. Episodes of hypoglycemia and cardiac autonomic neuropathy further increase the likelihood of dangerous heart rhythm disturbances. On a population level, diabetes also shortens life expectancy. The same Danish study reported that type 1 diabetes reduces average life expectancy by 14.2 years, and type 2 diabetes by 7.9 years, with SCD accounting for a notable proportion of these lost years. Exercise as a Key Strategy to Reduce Cardiovascular Risk Lifestyle modification, particularly structured exercise, is one of the most effective strategies for reducing cardiovascular risk in people with T2D. A 2025 systematic review published in Diabetology compared the effects of aerobic, resistance, and combined exercise training on cardiovascular outcomes in adults with T2D. The review found that aerobic exercise alone can reduce systolic and diastolic blood pressure by 6 mmHg and 3 mmHg respectively. It also improves cholesterol levels, including an 8% reduction in LDL and a 5% increase in HDL. Resistance training improves lean muscle mass, insulin sensitivity, and contributes modestly to lowering inflammation. The most pronounced cardiovascular benefits were observed with combined aerobic and resistance training. This approach achieved larger reductions in blood pressure, LDL cholesterol, and inflammatory markers, alongside a 15% improvement in heart rate variability. These findings underscore the value of a holistic exercise program as a cornerstone of cardiovascular prevention in T2D. Source: https://www.mdpi.com/2673-4540/6/5/38 Rethinking Risk Screening: Why Traditional Tools Can Miss Heart Events While diabetes significantly increases heart risk, standard screening tools may still miss many individuals at risk for acute events. An 2025 open-access study in JACC : Advances highlighted that nearly half of patients presenting with their first myocardial infarction had low or borderline ASCVD risk scores. Most experienced no symptoms until just before their cardiac event. The study emphasized that both ASCVD and newer risk calculators, such as the PREVENT tool , fail to identify many at-risk individuals under 66 years old. Notably, 60% of participants did not develop symptoms until within 48 hours of their event. These findings reveal a critical gap in traditional, risk-based screening. They underscore the importance of proactive lifestyle interventions, personalized care, and, where appropriate, imaging-based assessment of subclinical atherosclerosis. Personalized Interventions & Clinical Guidance Effective cardiovascular prevention in diabetes requires an integrated approach. Structured exercise combining aerobic and resistance training, early optimization of medications such as SGLT2 inhibitors, GLP-1 receptor agonists, and statins, and advanced cardiovascular monitoring can all contribute to reduced risk. Younger adults, particularly those with type 1 diabetes, may benefit from early intervention and personalized treatment strategies. Practical Cardiac Resources for Canadian Healthcare Providers Healthcare providers in Canada can access practical resources for assessing and managing cardiovascular risk in patients with diabetes. The Canadian Cardiovascular Society (CCS) calculators and forms provide validated tools for risk assessment tailored to Canadian populations. The Heart & Stroke Foundation Risk Screening offers an interactive tool for evaluating patient risk and generating personalized recommendations. CardioRisk Calculator ™ is a clinical tool to streamline heart disease risk assessment based on national Canadian dyslipidemia guidelines. Additionally, the CCS Companion Resources provide infographics, algorithms, and printable handouts to support guideline implementation. Clinicians can also utilize Hypertension Canada’s clinician resources for guidance on managing a major modifiable risk factor in diabetes. Protecting Your Heart with Diabetes For patients, key steps include monitoring blood sugar, blood pressure, and cholesterol regularly. Maintaining an active lifestyle with combined aerobic and resistance exercise is crucial. Engaging in ongoing discussions with healthcare providers about preventive strategies and advanced monitoring is also essential. These proactive steps, along with evidence-based treatment and personalized interventions, can significantly reduce cardiovascular risk and improve long-term health outcomes in people with diabetes.

Key Insights ✅ GLP-1s help lower blood sugar and shed weight in T2D. ✅ Benefits often fade after stopping, and weight can return. ✅ Muscle loss is possible; exercise helps. ✅ Best results come from combining medication with lifestyle support. Weight-loss medications, especially GLP-1–based drugs like semaglutide and tirzepatide, have transformed obesity treatment. Double-digit percentage weight loss, rapid metabolic improvements, and strong cardiovascular signals have driven unprecedented demand. But a crucial question has lingered behind the headlines: what happens when people stop taking these drugs? A major new BMJ systematic review and meta-analysis (January 2026) offers the clearest answer yet, and the findings should reshape how clinicians, policymakers, and patients think about weight-loss medications. In this review of 37 studies covering over 9,300 participants found that after stopping weight-loss medication, people regain weight at an average of ~0.4 kg per month, returning to baseline weight in about 1.7 years. For newer GLP-1 medications, regain can be even faster, around 0.8 kg per month. Even though these drugs produce larger initial weight losses than lifestyle programs, the rebound is steeper. Behavioral programs like diet and exercise interventions may produce slower initial losses, but they also teach coping skills that help maintain weight loss longer, often nearly twice as long as medication alone. Graphical abstract West et al. 2026 Weight loss isn’t the only thing that reverses. GLP-1s improve key cardiometabolic markers, including blood sugar, blood pressure, and cholesterol, but these benefits largely disappear within 12–18 months of stopping treatment. This challenges the idea that a period of drug-induced weight loss can “reset” metabolic risk permanently. Why Stopping GLP-1s Matters for People with T2D For people with T2D, these findings are particularly important. Diabetes is a chronic, progressive condition, and GLP-1s are a management tool, not a cure. Stopping medication often means both weight and blood sugar levels rise again, potentially undoing months of effort. Muscle loss is another consideration. Up to 40% of the weight lost on GLP-1 therapy may come from lean body mass. Without resistance training and proper nutrition, repeated cycles of weight loss and regain could lead to sarcopenic obesity, especially in older adults. Lifestyle Still Matters We've said it before and here it is again. The evidence reinforces a simple truth: medication alone is rarely enough. Lifestyle interventions, structured nutrition, regular exercise, stress management, remain essential for lasting benefits. Think of GLP-1s as powerful tools that work best when integrated into a long-term metabolic health plan. Without a long-term strategy, weight-loss drugs alone are unlikely to solve a chronic problem. One of the most revealing aspects of the study is its comparison with behavioural weight management programmes (BWMPs) such as diet and physical activity interventions. Although medications led to greater initial weight loss, the rebound was much steeper: Even after adjusting for how much weight people lost initially, regain was consistently faster after medication than after behavioural programmes. Intervention Monthly weight regain after stopping GLP-1a Time to return to baseline weight prior to GLP-1a Weight-loss medication ~0.4 kg/month ~1.7 years Behavioural programmes ~0.1 kg/month ~3.9 years Weight loss is real. Regain is real too. And for people with T2D, planning for both is the key to sustained health. What Other GLP-1 Evidence Shows: Beyond the Headlines It’s worth looking at what peer‑reviewed science tells us about GLP‑1 medications and weight rebound. Multiple systematic reviews and meta‑analyses confirm that significant weight regain tends to occur after stopping GLP‑1 receptor agonists, including semaglutide and tirzepatide. One meta‑analysis found that after discontinuation, participants regained several kilograms of body weight proportional to the amount lost on therapy, underscoring the biologic drive to return to prior weight without ongoing medication support. Moreover, structured analyses show that not only does weight return, but cardiometabolic markers such as HbA1c, blood pressure, and lipid levels also deteriorate once treatment stops, particularly in people with T2D or obesity. This metabolic rebound highlights that the advantages gained during active therapy are not always durable unless sustained by long‑term intervention. However, the story isn’t entirely one‑sided. Other research suggests that combining GLP‑1 therapy with lifestyle modification, like diet and exercise, produces larger and more favorable effects on weight and cardiometabolic biomarkers than medication alone, pointing to the powerful synergy between drugs and behavior change. Rethinking Duration, Expectations, and T2D Management Recognizing T2D as a chronic, progressive disease means asking different questions about GLP‑1s: Should these medications be used long‑term or even lifelong for many patients? What strategies help preserve metabolic gains if therapy is tapered or stopped? Some analyses argue that short‑term courses may fall short for lasting benefit unless paired with sustained lifestyle changes and realistic planning around discontinuation. It’s also important to tailor expectations: while GLP‑1s are highly effective tools for lowering blood sugar and reducing weight, they are not a cure for the underlying metabolic dysfunction of T2D. Durable improvements most often come from comprehensive care plans that integrate medication, nutrition, physical activity, and behavior support over years, not just months. Toward Better Long‑Term Support GLP-1 medications are transformative for glycemic control, weight loss, and cardiovascular risk in T2D, but only while they’re taken. Long-term success depends on combining medication with lifestyle support and realistic planning around discontinuation. Looking ahead, r esearchers continue to explore how to optimize GLP‑1 use in chronic care. This includes studying whether extended treatment durations, tapering strategies, or combined therapeutic approaches could lessen rebound effects after stopping, or even transform how we think about long‑term T2D and obesity management. In the meantime, the weight loss is clear, and so is the challenge of maintaining it. For people with T2D, the best outcomes usually emerge when GLP‑1 medications are part of a broader, sustained plan that includes lifestyle support, realistic expectations, and ongoing conversations between patients and clinicians about goals, duration of therapy, and what happens next.